Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445))

Kristof De Vos; Adamantios Mavrogiannis; Justina Clarinda Wolters; Susan Schlenner; Keimpe Wierda; Álvaro Cortés Calabuig; Reena Chinnaraj; Vera Dermesrobian; Yeghig Armoudjian; Maarten Jacquemyn; Nikky Corthout; Dirk Daelemans; Pieter Annaert

doi:10.1016/j.bcp.2024.116497

Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445))

Kristof De Vos
, Adamantios Mavrogiannis
, Justina Clarinda Wolters
, Susan Schlenner
, Keimpe Wierda
, Álvaro Cortés Calabuig
, Reena Chinnaraj
, Vera Dermesrobian
, Yeghig Armoudjian
, Maarten Jacquemyn
, Nikky Corthout
, Dirk Daelemans
, Pieter Annaert^*

^*Corresponding author for this work

Research output: Contribution to journal › Erratum

Abstract

In Table 5–8, the second column always represents the “-log(p-value)” instead of the “p-value” as it is currently labelled. We would also like clarify that in Figure 1, the variation shown in the bar graph (Fig. 1A) and line graph (Fig. 1B) represents the standard deviation. The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	116497
Journal	Biochemical Pharmacology
Volume	229
DOIs	https://doi.org/10.1016/j.bcp.2024.116497
Publication status	Published - Nov-2024

Access to Document

10.1016/j.bcp.2024.116497

Handle.net

Persistent link

Fingerprint

Dive into the research topics of 'Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445))'. Together they form a unique fingerprint.

1 Article

Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells
De Vos, K., Mavrogiannis, A., Clarinda Wolters, J., Schlenner, S., Wierda, K., Cortés Calabuig, Á., Chinnaraj, R., Dermesrobian, V., Armoudjian, Y., Jacquemyn, M., Corthout, N., Daelemans, D. & Annaert, P., Sept-2024, In: Biochemical Pharmacology. 227, 116445.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File
2 Citations (Scopus)

54 Downloads (Pure)

Cite this

De Vos, K., Mavrogiannis, A., Wolters, J. C., Schlenner, S., Wierda, K., Calabuig, Á. C., Chinnaraj, R., Dermesrobian, V., Armoudjian, Y., Jacquemyn, M., Corthout, N., Daelemans, D., & Annaert, P. (2024). Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445)). Biochemical Pharmacology, 229, Article 116497. https://doi.org/10.1016/j.bcp.2024.116497

De Vos, Kristof ; Mavrogiannis, Adamantios ; Wolters, Justina Clarinda et al. / Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445)). In: Biochemical Pharmacology. 2024 ; Vol. 229.

@article{acf3070af02949e091c9bb11b87db407,

title = "Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445))",

abstract = "In Table 5–8, the second column always represents the “-log(p-value)” instead of the “p-value” as it is currently labelled. We would also like clarify that in Figure 1, the variation shown in the bar graph (Fig. 1A) and line graph (Fig. 1B) represents the standard deviation. The authors would like to apologise for any inconvenience caused.",

author = "\{De Vos\}, Kristof and Adamantios Mavrogiannis and Wolters, \{Justina Clarinda\} and Susan Schlenner and Keimpe Wierda and Calabuig, \{{\'A}lvaro Cort{\'e}s\} and Reena Chinnaraj and Vera Dermesrobian and Yeghig Armoudjian and Maarten Jacquemyn and Nikky Corthout and Dirk Daelemans and Pieter Annaert",

note = "Publisher Copyright: {\textcopyright} 2024 Elsevier Inc.",

year = "2024",

month = nov,

doi = "10.1016/j.bcp.2024.116497",

language = "English",

volume = "229",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

}

De Vos, K, Mavrogiannis, A, Wolters, JC, Schlenner, S, Wierda, K, Calabuig, ÁC, Chinnaraj, R, Dermesrobian, V, Armoudjian, Y, Jacquemyn, M, Corthout, N, Daelemans, D & Annaert, P 2024, 'Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445))', Biochemical Pharmacology, vol. 229, 116497. https://doi.org/10.1016/j.bcp.2024.116497

Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445)). / De Vos, Kristof; Mavrogiannis, Adamantios; Wolters, Justina Clarinda et al.
In: Biochemical Pharmacology, Vol. 229, 116497, 11.2024.

Research output: Contribution to journal › Erratum

TY - JOUR

T1 - Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445))

AU - De Vos, Kristof

AU - Mavrogiannis, Adamantios

AU - Wolters, Justina Clarinda

AU - Schlenner, Susan

AU - Wierda, Keimpe

AU - Calabuig, Álvaro Cortés

AU - Chinnaraj, Reena

AU - Dermesrobian, Vera

AU - Armoudjian, Yeghig

AU - Jacquemyn, Maarten

AU - Corthout, Nikky

AU - Daelemans, Dirk

AU - Annaert, Pieter

PY - 2024/11

Y1 - 2024/11

N2 - In Table 5–8, the second column always represents the “-log(p-value)” instead of the “p-value” as it is currently labelled. We would also like clarify that in Figure 1, the variation shown in the bar graph (Fig. 1A) and line graph (Fig. 1B) represents the standard deviation. The authors would like to apologise for any inconvenience caused.

AB - In Table 5–8, the second column always represents the “-log(p-value)” instead of the “p-value” as it is currently labelled. We would also like clarify that in Figure 1, the variation shown in the bar graph (Fig. 1A) and line graph (Fig. 1B) represents the standard deviation. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85201688734

U2 - 10.1016/j.bcp.2024.116497

DO - 10.1016/j.bcp.2024.116497

M3 - Erratum

C2 - 39178689

AN - SCOPUS:85201688734

SN - 0006-2952

VL - 229

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

M1 - 116497

ER -

De Vos K, Mavrogiannis A, Wolters JC, Schlenner S, Wierda K, Calabuig ÁC et al. Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445)). Biochemical Pharmacology. 2024 Nov;229:116497. doi: 10.1016/j.bcp.2024.116497

Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445] (Biochemical Pharmacology (2024) 227, (S0006295224004283), (10.1016/j.bcp.2024.116445))

Abstract

Access to Document

Handle.net

Other files and links

Fingerprint

Research output

Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells

Cite this